Codex Capital Asset Management L.L.C. Cuts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Codex Capital Asset Management L.L.C. lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 63.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,000 shares of the healthcare conglomerate’s stock after selling 1,700 shares during the quarter. Codex Capital Asset Management L.L.C.’s holdings in UnitedHealth Group were worth $514,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. First Financial Bankshares Inc increased its position in shares of UnitedHealth Group by 0.3% in the fourth quarter. First Financial Bankshares Inc now owns 38,193 shares of the healthcare conglomerate’s stock valued at $19,320,000 after buying an additional 112 shares in the last quarter. Generali Investments Management Co LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $2,258,000. Bank of Marin lifted its holdings in shares of UnitedHealth Group by 28.3% in the fourth quarter. Bank of Marin now owns 1,069 shares of the healthcare conglomerate’s stock valued at $541,000 after purchasing an additional 236 shares in the last quarter. North Forty Two & Co. purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $586,000. Finally, VSM Wealth Advisory LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $56,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on UNH shares. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Piper Sandler lowered their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Stock Up 0.9 %

Shares of NYSE UNH opened at $503.61 on Wednesday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a fifty day moving average price of $510.90 and a 200 day moving average price of $548.54. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $460.66 billion, a P/E ratio of 32.49, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 EPS. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.67%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.